Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
Johnson & JohnsonJNJ |
73 0% |
 |
Eli Lilly and CompanyLLY |
83 0% |
 |
PfizerPFE |
53 1.9% |
 |
AstrazenecaAZN |
82 0% |
 |
AbbVieABBV |
77 1.3% |
Month over Month
Employee view on business outlook (0 - 100)
| Oct 2024 | 48 | |
| Sep 2024 | 47 | |
| Aug 2024 | 51 | |
| Jul 2024 | 52 | |
| Jun 2024 | 51 |
How do employees feel about the future at Moderna?
The Business Outlook at Moderna is negative, according to employees. The rating, which is an average compiled from the top review sites in the US, is below average at 48 out of 100. Additionally, this rating has been trending downward in comparison to the previous month.
Analyzing Business Outlook, how is Moderna performing compared to its industry peers?
Compared to its peers, Moderna ranks in the 48th percentile when it comes to Business Outlook.
How has the business outlook at Moderna changed over the last couple of months
In recent months, Moderna's employees have reported a shift towards a more negative business outlook, suggesting declining company morale and potentially leading to decreased market competitiveness and diminished company performance.
Why is it important to track the business outlook at Moderna?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Moderna.
